BETA

3 Amendments of Nicolae ŞTEFĂNUȚĂ related to 2019/2816(RSP)

Amendment 164 #

Paragraph 16
16. Considers thatalls on the Commission to make a legislative proposal to include the environmental impacts of pharmaceuticals could be includedthat are not deemed essential, into the benefit-risk assessment of human medicines, as is already the case for veterinary medicines;
2020/01/30
Committee: ENVI
Amendment 170 #

Paragraph 17
17. Calls the Commission to take into account, where appropriate, ongoing existing efforts by stakeholders for future initiatives to reduce environmental risks and promote environmentally responsible practices and appropriate use and return of pharmaceuticals;
2020/01/30
Committee: ENVI
Amendment 207 #

Paragraph 27 a (new)
27 a. Calls for measurable targets to be put into place with the aim of reducing overall prescription and consumption of pharmaceuticals both in human and animal veterinary;
2020/01/30
Committee: ENVI